• Coronavirus Macrodomain Counters PARP-Mediated Antiviral Def

  2026-06-08

  This study uncovers how the coronavirus macrodomain enables viral replication by reversing PARP-mediated ADP-ribosylation, dampening host antiviral responses. The findings clarify the molecular interplay between viral macrodomains and host poly (ADP-ribose) polymerases, highlighting new antiviral targets and experimental strategies.

• Stattic (SKU A2224): Reliable STAT3 Inhibition for Cancer &

  2026-06-08

  This article guides biomedical researchers and lab technicians in addressing reproducibility and workflow challenges in STAT3 pathway studies. It demonstrates how Stattic (SKU A2224), a potent STAT3 inhibitor, delivers data-backed, protocol-friendly solutions in cancer biology and apoptosis induction. Scenario-driven Q&A blocks provide actionable insights and highlight why Stattic is a preferred reagent for sensitive cell-based assays.

• Berberine Modulates SASP Inflammation via RXRα/PPARγ/NEDD4 P

  2026-06-07

  The referenced study uncovers how berberine suppresses senescence-associated secretory phenotype (SASP) inflammation in atherosclerosis by targeting the RXRα/PPARγ/NEDD4 signaling axis. This mechanistic insight clarifies the link between cellular senescence and vascular inflammation, providing a foundation for directed interventions in age-related vascular disease.

• PDE-5-Inhibited BMSCs Mitigate Diabetic Myocardial Fibrosis

  2026-06-06

  This study demonstrates that bone marrow mesenchymal stem cells (BMSCs) with suppressed phosphodiesterase-5 (PDE-5) expression can protect against high glucose-induced myocardial fibrosis and cardiomyocyte apoptosis by activating the cGMP/PKG pathway. The findings clarify a mechanistic basis for stem cell-based interventions in diabetic cardiomyopathy and highlight specific molecular targets for future therapeutic research.

• Sumatriptan's Anti-Inflammatory Role: Systematic Review Insi

  2026-06-05

  Ala et al. systematically reviewed evidence indicating that sumatriptan, beyond its established anti-migraine effects, exhibits substantial anti-inflammatory activity via modulation of cytokines, nitric oxide signaling, and neuropeptide release. These findings highlight new directions for drug repositioning and cross-domain research in inflammation and pharmacology.

• 3-Methyladenine: Strategic Autophagy Inhibition in Translati

  2026-06-05

  This thought-leadership article explores the mechanistic underpinnings and translational opportunities presented by 3-Methyladenine (3-MA) as an advanced autophagy inhibitor. Integrating recent discoveries on ferroptosis resistance in bladder cancer, the piece provides actionable guidance for researchers navigating the phosphoinositide 3-kinase (PI3K) signaling pathway, autophagy research, and cell migration inhibition. The discussion contextualizes 3-MA’s unique properties within the competitive landscape and offers a forward-looking perspective on its role in experimental oncology.

• Mildronate-Derived Lipidoids Enable Efficient mRNA Vaccine D

  2026-06-04

  The referenced ACS Nano study introduces mildronate-derived cationic lipidoids as innovative components for mRNA lipid nanoparticles, achieving high delivery efficiency with minimal inflammatory side effects in preclinical melanoma models. These findings point to promising strategies for safer, more effective mRNA vaccine platforms, offering translational value for immunology and therapeutic research.

• KPT330 Enhances CRISPR-Cas9 Precision by Regulating mRNA Exp

  2026-06-04

  The reference study identifies KPT330, a selective inhibitor of nuclear export, as an indirect and irreversible modulator that improves the specificity of CRISPR-Cas9 genome and base editing. By targeting mRNA nuclear export rather than Cas9 protein function directly, this approach offers a novel strategy to mitigate off-target effects in mammalian genome engineering.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-06-03

  Wang et al. uncover a novel METTL16-SENP3-LTF signaling axis that confers resistance to ferroptosis and promotes tumorigenesis in hepatocellular carcinoma (HCC) by modulating iron metabolism through m6A-dependent pathways. These insights suggest that targeting this axis could sensitize HCC cells to ferroptosis-based therapies and improve clinical outcomes.

• 17-AAG (Tanespimycin): Optimizing HSP90 Inhibition in Cancer

  2026-06-03

  17-AAG (Tanespimycin) delivers potent, selective HSP90 chaperone inhibition, enabling researchers to destabilize oncogenic pathways in challenging cancer models. This guide integrates advanced experimental workflows, protocol enhancements, and troubleshooting strategies—bridging recent mechanistic insights on cell death with actionable oncology research applications.

• LG 101506: Strategic RXR Modulation in Translational Oncolog

  2026-06-02

  Explore how LG 101506, a synthetic RXR modulator, enables new frontiers in RXR signaling pathway research and immuno-oncology, especially in the context of immune checkpoint regulation in triple-negative breast cancer. This article provides mechanistic insights, practical protocol parameters, and a forward-looking perspective for translational researchers seeking to bridge nuclear receptor biology with innovative therapeutic strategies.

• Norovirus Hijacks NINJ1 for Selective Viral Protein Secretio

  2026-06-02

  Song et al. reveal that murine norovirus co-opts the host membrane protein NINJ1 to enable selective secretion of its NS1 protein, bypassing canonical secretion pathways. This study uncovers a novel mechanism by which viruses manipulate host cell death and protein release processes, with implications for understanding regulated membrane rupture and unconventional secretion.

• ML216: Potent BLM Helicase Inhibitor for DNA Repair Research

  2026-06-01

  ML216 is a selective BLM helicase inhibitor that disrupts homologous recombination-mediated DNA repair. It demonstrates submicromolar potency and high selectivity, enabling precise interrogation of DNA repair pathways in vitro and in vivo. ML216, supplied by APExBIO, is validated for both mechanistic studies and synthetic lethality assays in cancer research.

• Disodium bicinchoninate (SKU C6645): Reliable Assay Reagent

  2026-06-01

  This article provides scenario-driven, evidence-based guidance for biomedical researchers seeking reliable, water-soluble assay reagents. Using Disodium bicinchoninate (SKU C6645), we address real laboratory challenges in cell viability and molecular biology assays, with practical recommendations grounded in product specifications and scientific literature.

• Mitomycin C: Antitumor Antibiotic Workflows & Optimization

  2026-05-31

  Mitomycin C, a gold-standard antitumor antibiotic, enables precise DNA replication inhibition and advanced apoptosis signaling research. This guide provides actionable workflows, troubleshooting advice, and unique insights for maximizing data quality in cancer research models.

15836 records 1/1056 page Next 12345 下5页 Last page